Europe Precision Medicine Market Size, Share Global Analysis Report, 2018 – 2025

Name: Europe Precision Medicine Market By Technology (Big Data Analytics, Gene Sequencing, Companion Diagnostics, Bioinformatics, Drug Discovery, and Others), By End-User(Diagnostic Tool Companies, Clinical Labs, Healthcare IT/Big Data Companies, and Pharma & Biotech Companies), and By Application (Oncology, Respiratory, CNS, Immunology, and Others): Industry Perspective, Comprehensive Analysis, and Forecast 2018 – 2025
Creator: Facts and Factors
License: https://www.fnfresearch.com/privacy-policy

Press Release

Europe Precision Medicine Market Revenue Estimated Around USD 40,487 Million By 2025

Europe Precision Medicine Market By Technology (Big Data Analytics, Gene Sequencing, Companion Diagnostics, Bioinformatics, Drug Discovery, and Others), By End-User(Diagnostic Tool Companies, Clinical Labs, Healthcare IT/Big Data Companies, and Pharma & Biotech Companies), and By Application (Oncology, Respiratory, CNS, Immunology, and Others): Industry Perspective, Comprehensive Analysis, and Forecast 2018 – 2025

Industry Insights

The report covers the forecast and analysis of the Europe Precision Medicine market. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the Europe Precision Medicine market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Europe Precision Medicine market.

Global Europe Precision Medicine Market Size

To know more about this report | Request Free Sample Copy

In order to give the users of this report a comprehensive view of the Europe Precision Medicine market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the Europe Precision Medicine market by segmenting the market based on technology, end-user, application, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025.

Patient outcomes are likely to be improved through the utility of precision drugs in the European continent. It comprises of medical institutes ready to make genetic testing & analytics tools and investors willing to compensate the drug costs. Apart from this, drug institutes in Europe are focusing on creating new personalized modes of treatments while companion diagnostics providers are concentrating on gathering data efficiently. Additionally, genetic analytics help in interpreting the outcomes of the clinical data of the patients.

Report Scope

Report Attribute	Details
Market Size in 2018	USD 17,132 Million
Projected Market Size in 2025	USD 40,487 Million
CAGR Growth Rate	13.1% CAGR
Base Year	2018
Forecast Years	2018-2025
Key Market Players	Thermo Fisher Scientific, Cepheid, Intel Corporation, Randox Laboratories, Novartis, Almac Group, Illumina, Johnson & Johnson, Qiagen, GE Healthcare, Roche, IBM, Laboratory Corporation of America Holdings, Abbott Laboratories, Biomrieux Sa, and Healthcore, and Others
Key Segment	By Technology, End-User, Application, and Region
Major Regions Covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Purchase Options	Request customized purchase options to meet your research needs.Explore purchase options

The Europe precision medicine industry is sectored based on technology, end-user, and application. Based on the technology, the industry is segregated into Big Data Analytics, Gene Sequencing, Companion Diagnostics, Bioinformatics, Drug Discovery, and Others, In terms of end-user, the precision medicine market in Europe is classified into Diagnostic Tool Companies, Clinical Labs, Healthcare IT/Big Data Companies, and Pharma & Biotech Companies. Application-wise the market is divided into Oncology, Respiratory, CNS, Immunology, and Others.

Top Players in the Market Are:

Some of the key players involved in the business includer

Thermo Fisher Scientific
Cepheid
Intel Corporation
Randox Laboratories
Novartis
Almac Group
Illumina
Johnson & Johnson
Qiagen
GE Healthcare
Roche
IBM
Laboratory Corporation of America Holdings
Abbott Laboratories
Biomrieux Sa
Healthcare among othes

This report segments the Europe Precision Medicine market as follows:

By Technology Analysis

Big Data Analytics
Gene Sequencing
Companion Diagnostics
Bioinformatics
Drug Discovery
Others

By End-User Analysis

Diagnostic Tool Companies
Clinical Labs
Healthcare IT/Big Data Companies
Pharma & Biotech Companies

By Application Analysis

Oncology
Respiratory
CNS
Immunology
Others

By Country-wise Segment Analysis

Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
  - Denmark
  - Finland
  - Iceland
  - Sweden
  - Norway
- Benelux Union
  - Belgium
  - The Netherlands
  - Luxembourg
- Rest of Europe

Table of Content

CHAPTER 1. Executive Summary 19
CHAPTER 2. Europe Precision Medicine market – Technology Analysis 22
1. 2.1. Europe Precision Medicine Market – Technology Overview 22
2. 2.2. Europe Precision Medicine Market Share, by Technology, 2018 & 2025 (USD Million) 22
3. 2.3. Big Data Analytics 24
  1. 2.3.1. Big Data Analytics Europe Precision Medicine Market, 2015-2025 (USD Million) 24
4. 2.4. Gene Sequencing 25
  1. 2.4.1. Gene Sequencing Europe Precision Medicine Market, 2015-2025 (USD Million) 25
5. 2.5. Companion Diagnostics 26
  1. 2.5.1. Companion Diagnostics Europe Precision Medicine Market, 2015-2025 (USD Million) 26
6. 2.6. Bioinformatics 27
  1. 2.6.1. Bioinformatics Europe Precision Medicine Market, 2015-2025 (USD Million) 27
7. 2.7. Drug Discovery 28
  1. 2.7.1. Drug Discovery Europe Precision Medicine Market, 2015-2025 (USD Million) 28
8. 2.8. Others 29
  1. 2.8.1. Others Europe Precision Medicine Market, 2015-2025 (USD Million) 29
CHAPTER 3. Europe Precision Medicine market – End-User Analysis 29
1. 3.1. Europe Precision Medicine Market – End-User Overview 29
2. 3.2. Europe Precision Medicine Market Share, by End-User, 2018 & 2025 (USD Million) 30
3. 3.3. Diagnostic Tool Companies 31
  1. 3.3.1. Diagnostic Tool Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 31
4. 3.4. Clinical Labs 32
  1. 3.4.1. Clinical Labs Europe Precision Medicine Market, 2015-2025 (USD Million) 32
5. 3.5. Healthcare IT/Big Data Companies 33
  1. 3.5.1. Healthcare IT/Big Data Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 33
6. 3.6. Pharma & Biotech Companies 34
  1. 3.6.1. Pharma & Biotech Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 34
CHAPTER 4. Europe Precision Medicine market – Application Analysis 34
1. 4.1. Europe Precision Medicine Market – Application Overview 34
2. 4.2. Europe Precision Medicine Market Share, by Application, 2018 & 2025 (USD Million) 35
3. 4.3. Oncology 36
  1. 4.3.1. Oncology Europe Precision Medicine Market, 2015-2025 (USD Million) 36
4. 4.4. Respiratory 37
  1. 4.4.1. Respiratory Europe Precision Medicine Market, 2015-2025 (USD Million) 37
5. 4.5. CNS 38
  1. 4.5.1. CNS Europe Precision Medicine Market, 2015-2025 (USD Million) 38
6. 4.6. Immunology 39
  1. 4.6.1. Immunology Europe Precision Medicine Market, 2015-2025 (USD Million) 39
7. 4.7. Others 40
  1. 4.7.1. Others Europe Precision Medicine Market, 2015-2025 (USD Million) 40
CHAPTER 5. Europe Precision Medicine market – Regional Analysis 41
1. 5.1. Europe Precision Medicine Market Regional Overview 41
2. 5.2. Europe Precision Medicine Market Share, by Region, 2018 & 2025 (Value) 41
3. 5.3. Europe 42
  1. 5.3.1. Europe Precision Medicine Market size and forecast, 2015-2025 42
  2. 5.3.2. Europe Precision Medicine Market, by Country, 2018 & 2025 (USD Million) 42
  3. 5.3.3. Europe Precision Medicine Market, by Technology, 2015-2025 44
    1. 5.3.3.1. Europe Precision Medicine Market, by Technology, 2015-2025 (USD Million) 44
  4. 5.3.4. Europe Precision Medicine Market, by End-User, 2015-2025 45
    1. 5.3.4.1. Europe Precision Medicine Market, by End-User, 2015-2025 (USD Million) 45
  5. 5.3.5. Europe Precision Medicine Market, by Application, 2015-2025 46
    1. 5.3.5.1. Europe Precision Medicine Market, by Application, 2015-2025 (USD Million) 46
  6. 5.3.6. Germany 47
    1. 5.3.6.1. Germany Market size and forecast, 2015-2025 (USD Million) 47
  7. 5.3.7. France 48
    1. 5.3.7.1. France Market size and forecast, 2015-2025 (USD Million) 48
  8. 5.3.8. U.K. 49
    1. 5.3.8.1. U.K. Market size and forecast, 2015-2025 (USD Million) 49
  9. 5.3.9. Italy 50
    1. 5.3.9.1. Italy Market size and forecast, 2015-2025 (USD Million) 50
  10. 5.3.10. Spain 51
    1. 5.3.10.1. Spain Market size and forecast, 2015-2025 (USD Million) 51
  11. 5.3.11. Nordic Countries 52
    1. 5.3.11.1. Nordic Countries Market size and forecast, 2015-2025 (USD Million) 52
  12. 5.3.12. Benelux Union 53
    1. 5.3.12.1. Benelux Union Market size and forecast, 2015-2025 (USD Million) 53
  13. 5.3.13. Rest of Europe 54
    1. 5.3.13.1. Rest of Europe Market size and forecast, 2015-2025 (USD Million) 54
CHAPTER 6. Europe Precision Medicine market – Competitive Landscape 55
1. 6.1. Competitor Market Share – Revenue 55
2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 57
3. 6.3. Strategic Development 58
  1. 6.3.1. Acquisitions and Mergers 58
  2. 6.3.2. New Products 58
  3. 6.3.3. Research & Development Activities 58
CHAPTER 7. Company Profiles 59
1. 7.1. Thermo Fisher Scientific 59
  1. 7.1.1. Company Overview 59
  2. 7.1.2. Thermo Fisher Scientific Revenue and Gross Margin 59
  3. 7.1.3. Product portfolio 60
  4. 7.1.4. Recent initiatives 61
2. 7.2. Cepheid 61
  1. 7.2.1. Company Overview 61
  2. 7.2.2. Cepheid Revenue and Gross Margin 61
  3. 7.2.3. Product portfolio 62
  4. 7.2.4. Recent initiatives 63
3. 7.3. Intel Corporation 63
  1. 7.3.1. Company Overview 63
  2. 7.3.2. Intel Corporation Revenue and Gross Margin 63
  3. 7.3.3. Product portfolio 64
  4. 7.3.4. Recent initiatives 65
4. 7.4. Randox Laboratories 65
  1. 7.4.1. Company Overview 65
  2. 7.4.2. Randox Laboratories Revenue and Gross Margin 65
  3. 7.4.3. Product portfolio 66
  4. 7.4.4. Recent initiatives 67
5. 7.5. Novartis 67
  1. 7.5.1. Company Overview 67
  2. 7.5.2. Novartis Revenue and Gross Margin 67
  3. 7.5.3. Product portfolio 68
  4. 7.5.4. Recent initiatives 69
6. 7.6. Almac Group 69
  1. 7.6.1. Company Overview 69
  2. 7.6.2. Almac Group Revenue and Gross Margin 69
  3. 7.6.3. Product portfolio 70
  4. 7.6.4. Recent initiatives 71
7. 7.7. Illumina 71
  1. 7.7.1. Company Overview 71
  2. 7.7.2. Illumina Revenue and Gross Margin 71
  3. 7.7.3. Product portfolio 72
  4. 7.7.4. Recent initiatives 73
8. 7.8. Johnson & Johnson 73
  1. 7.8.1. Company Overview 73
  2. 7.8.2. Johnson & Johnson Revenue and Gross Margin 73
  3. 7.8.3. Product portfolio 74
  4. 7.8.4. Recent initiatives 75
9. 7.9. Qiagen 75
  1. 7.9.1. Company Overview 75
  2. 7.9.2. Qiagen Revenue and Gross Margin 75
  3. 7.9.3. Product portfolio 76
  4. 7.9.4. Recent initiatives 77
10. 7.10. GE Healthcare 77
  1. 7.10.1. Company Overview 77
  2. 7.10.2. GE Healthcare Revenue and Gross Margin 77
  3. 7.10.3. Product portfolio 78
  4. 7.10.4. Recent initiatives 79
11. 7.11. Roche 79
  1. 7.11.1. Company Overview 79
  2. 7.11.2. Roche Revenue and Gross Margin 79
  3. 7.11.3. Product portfolio 80
  4. 7.11.4. Recent initiatives 81
12. 7.12. IBM 81
  1. 7.12.1. Company Overview 81
  2. 7.12.2. IBM Revenue and Gross Margin 81
  3. 7.12.3. Product portfolio 82
  4. 7.12.4. Recent initiatives 83
13. 7.13. Laboratory Corporation of America Holdings 83
  1. 7.13.1. Company Overview 83
  2. 7.13.2. Laboratory Corporation of America Holdings Revenue and Gross Margin 83
  3. 7.13.3. Product portfolio 84
  4. 7.13.4. Recent initiatives 85
14. 7.14. Abbott Laboratories 85
  1. 7.14.1. Company Overview 85
  2. 7.14.2. Abbott Laboratories Revenue and Gross Margin 85
  3. 7.14.3. Product portfolio 86
  4. 7.14.4. Recent initiatives 87
15. 7.15. Biomrieux Sa 87
  1. 7.15.1. Company Overview 87
  2. 7.15.2. Biomrieux Sa Revenue and Gross Margin 87
  3. 7.15.3. Product portfolio 88
  4. 7.15.4. Recent initiatives 89
16. 7.16. Healthcore 89
  1. 7.16.1. Company Overview 89
  2. 7.16.2. Healthcore Revenue and Gross Margin 89
  3. 7.16.3. Product portfolio 90
  4. 7.16.4. Recent initiatives 91
CHAPTER 8. Europe Precision Medicine — Industry Analysis 92
1. 8.1. Europe Precision Medicine Market – Key Trends 92
  1. 8.1.1. Market Drivers 93
  2. 8.1.2. Market Restraints 93
  3. 8.1.3. Market Opportunities 94
2. 8.2. Value Chain Analysis 95
3. 8.3. Technology Roadmap and Timeline 96
4. 8.4. Europe Precision Medicine Market – Attractiveness Analysis 97
  1. 8.4.1. By Technology 97
  2. 8.4.2. By End-User 97
  3. 8.4.3. By Application 98
  4. 8.4.4. By Region 100
CHAPTER 9. Marketing Strategy Analysis, Distributors 101
1. 9.1. Marketing Channel 101
2. 9.2. Direct Marketing 102
3. 9.3. Indirect Marketing 102
4. 9.4. Marketing Channel Development Trend 102
5. 9.5. Economic/Political Environmental Change 103
CHAPTER 10. Report Conclusion 104

CHAPTER 11. Research Approach & Methodology 105

11.1. Report Description 105
11.2. Research Scope 106

11.3. Research Methodology 106

11.3.1. Secondary Research 107
11.3.2. Primary Research 108

11.3.3. Models 109

11.3.3.1. Company Share Analysis Model 109
11.3.3.2. Revenue Based Modeling 110
11.3.3.3. Research Limitations 110

List of Figures

FIG. 1  Europe Precision Medicine Market, 2015-2025 (USD Million) 22
FIG. 2  Europe Precision Medicine Market Share, by Technology, 2018 & 2025 (USD Million) 23
FIG. 3  Big Data Analytics Europe Precision Medicine Market, 2015-2025 (USD Million) 25
FIG. 4  Gene Sequencing Europe Precision Medicine Market, 2015-2025 (USD Million) 26
FIG. 5  Companion Diagnostics Europe Precision Medicine Market, 2015-2025 (USD Million) 27
FIG. 6  Bioinformatics Europe Precision Medicine Market, 2015-2025 (USD Million) 28
FIG. 7  Drug Discovery Europe Precision Medicine Market, 2015-2025 (USD Million) 29
FIG. 8  Others Europe Precision Medicine Market, 2015-2025 (USD Million) 30
FIG. 9  Europe Precision Medicine Market Share, by End-User, 2018 & 2025 (USD Million) 31
FIG. 10  Diagnostic Tool Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 32
FIG. 11  Clinical Labs Europe Precision Medicine Market, 2015-2025 (USD Million) 33
FIG. 12  Healthcare IT/Big Data Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 34
FIG. 13  Pharma & Biotech Companies Europe Precision Medicine Market, 2015-2025 (USD Million) 35
FIG. 14  Europe Precision Medicine Market Share, by Application, 2018 & 2025 (USD Million) 36
FIG. 15  Oncology Europe Precision Medicine Market, 2015-2025 (USD Million) 37
FIG. 16  Respiratory Europe Precision Medicine Market, 2015-2025 (USD Million) 38
FIG. 17  CNS Europe Precision Medicine Market, 2015-2025 (USD Million) 39
FIG. 18  Immunology Europe Precision Medicine Market, 2015-2025 (USD Million) 40
FIG. 19  Others Europe Precision Medicine Market, 2015-2025 (USD Million) 41
FIG. 20  Europe Precision Medicine Market Share, by Region, 2018 & 2025 42
FIG. 21 Europe Precision Medicine Market, 2015-2025 43
FIG. 22 Germany Europe Precision Medicine Market, 2015-2025 48
FIG. 23 France Europe Precision Medicine Market, 2015-2025 49
FIG. 24 U.K. Europe Precision Medicine Market, 2015-2025 50
FIG. 25 Italy Europe Precision Medicine Market, 2015-2025 51
FIG. 26 Spain Europe Precision Medicine Market, 2015-2025 52
FIG. 27 Nordic Countries Europe Precision Medicine Market, 2015-2025 53
FIG. 28 Benelux Union Europe Precision Medicine Market, 2015-2025 54
FIG. 29 Rest of Europe Precision Medicine Market, 2015-2025 55
FIG. 30 Competitor Market Share – Revenue 56
FIG. 31 Thermo Fisher Scientific Revenue and Growth Rate 61
FIG. 32 Thermo Fisher Scientific Market Share 61
FIG. 33 Cepheid Revenue and Growth Rate 63
FIG. 34 Cepheid Market Share 63
FIG. 35 Intel Corporation Revenue and Growth Rate 65
FIG. 36 Intel Corporation Market Share 65
FIG. 37 Randox Laboratories Revenue and Growth Rate 67
FIG. 38 Randox Laboratories Market Share 67
FIG. 39 Novartis Revenue and Growth Rate 69
FIG. 40 Novartis Market Share 69
FIG. 41 Almac Group Revenue and Growth Rate 71
FIG. 42 Almac Group Market Share 71
FIG. 43 Illumina Revenue and Growth Rate 73
FIG. 44 Illumina Market Share 73
FIG. 45 Johnson & Johnson Revenue and Growth Rate 75
FIG. 46 Johnson & Johnson Market Share 75
FIG. 47 Qiagen Revenue and Growth Rate 77
FIG. 48 Qiagen Market Share 77
FIG. 49 GE Healthcare Revenue and Growth Rate 79
FIG. 50 GE Healthcare Market Share 79
FIG. 51 Roche Revenue and Growth Rate 81
FIG. 52 Roche Market Share 81
FIG. 53 IBM Revenue and Growth Rate 83
FIG. 54 IBM Market Share 83
FIG. 55 Laboratory Corporation of America Holdings Revenue and Growth Rate 85
FIG. 56 Laboratory Corporation of America Holdings Market Share 85
FIG. 57 Abbott Laboratories Revenue and Growth Rate 87
FIG. 58 Abbott Laboratories Market Share 87
FIG. 59 Biomrieux Sa Revenue and Growth Rate 89
FIG. 60 Biomrieux Sa Market Share 89
FIG. 61 Healthcore Revenue and Growth Rate 91
FIG. 62 Healthcore Market Share 91
FIG. 63 Market Dynamics 93
FIG. 64  Europe Precision Medicine – Value Chain Analysis 96
FIG. 65 Technology Roadmap and Timeline 97
FIG. 66 Market Attractiveness Analysis – By Technology 98
FIG. 67 Market Attractiveness Analysis – By End-User 99
FIG. 68 Market Attractiveness Analysis – By Application 99
FIG. 69 Market Attractiveness Analysis – By Region 101
FIG. 70 Market Channel 102
FIG. 71 Marketing Channel Development Trend 103
FIG. 72 Growth in World Gross Product, 2008-2018 104

List of Tables

TABLE 1  Europe Precision Medicine Market, 2018 & 2025 (USD Million) 20
TABLE 2  Europe Precision Medicine market, by Technology, 2015-2025 (USD Million) 22
TABLE 3  Europe Precision Medicine market, by End-User, 2015-2025 (USD Million) 30
TABLE 4  Europe Precision Medicine market, by Application, 2015-2025 (USD Million) 35
TABLE 5  Europe Precision Medicine market, by Region, 2015-2025 (USD Million) 41
TABLE 6 Europe Precision Medicine Market, by Technology, 2015-2025 (USD Million) 44
TABLE 7 Europe Precision Medicine Market, by End-User, 2015-2025 (USD Million) 45
TABLE 8 Europe Precision Medicine Market, by Application, 2015-2025 (USD Million) 46
TABLE 9  Europe Precision Medicine Market - Company Revenue Analysis 2015-2018 (USD Million) 55
TABLE 10  Europe Precision Medicine Market - Company Revenue Share Analysis 2015-2018(%) 57
TABLE 11 Acquisitions and Mergers 58
TABLE 12 New Product/Service Launch 58
TABLE 13 Research & Development Activities 58
TABLE 14 Market Drivers 93
TABLE 15 Market Restraints 93
TABLE 16 Market Opportunities 94